SUBCLINICAL THYROID DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTAINANCE HEMODIALYSIS

Dr Nisha, Dr Nitish Patwardhan, Dr A. C. Tanna

Abstract


BACKGROUND : Chronic kidney disease(CKD) disrupts the homeostasis of the body by ill effects on various physiologic systems, endocrine
system being one of them . There have been many studies about thyroid dysfunction in persons with acute systemic illness and in CKD patients not
on maintainance hemodialysis. The data regarding prevalence of thyroid dysfunction in persons with chronic kidney disease (CKD) requiring
chronic dialysis is sparse.
OBJECTIVE:The present study was done to assess the prevalence and type of subclinical thyroid dysfunction in patients of chronic kidney
disease(CKD) on maintainance hemodialysis
STUDY METHODOLOGY: Cross-sectional data from 100 adult patients who were registered in the hemodialysis unit of Guru Gobindsingh
Civil Hospital, Jamnagar, Gujarat, India, was analyzed with Multivariable logistic regression analysis.The data consisted of estimated Glomerular
filtration rate (eGFR), calculated by the abbreviated Modification of Diet in Renal Disease(MDRD) equation and serum TSH, serum free T3 and
serum free T4.
RESULTS: Statistically nonsignificant negative correlation was found between estimated GFR and serum TSH, serum free T3, serum free T4
(Pearson's correlation r= - 0.178, - 0.052 and -0.110 respectively).
CONCLUSION: In our study we found that although subclinical thyroid dysfunction, more of subclinical hypothyroidism is detected in patients
of chronic kidney disease on maintainance hemodialysis, it is not statistically significant.


Keywords


CKD, Hemodialysis, Subclinical Thyroid Dysfunction, TSH, Serum Free T4

Full Text:

PDF

References


Helfand M.Screening for subclinical thyroid dysfunction in nonpregnant adults: A summary of the evidence for the U.S. Preventive Services Task Force, Annals of Internal Medicine,2004;140(2):128–141.

(2) Robin P Peeters,Theo J Visser.

Metabolism of Thyroid Hormone

[Updated 2017 Jan 1]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.

(3) Sang Heon Song Ihm Soo Kwak Dong Won Lee Yang Ho Kang Eun Young SeongJin Sup Park.The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone

Sang Heon Song, Ihm Soo Kwak et al, Nephrology Dialysis Transplantation, May 2009, 24(5):1534–1538

(4)Duntas LH, Wartofsky L.Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?, 2007, Thyroid, 17(11) :1075 –1084

(5) Rodondi N, Newman AB et al,Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine,2005,165 :2460 –2466

(6) Vayá, Amparo,Giménez et al.Subclinical hypothyroidism and cardiovascular risk, Clinical Hemorheology and Microcirculation, 2014, 58(1): 1-7

(7) Chen HS, Wu TE et al.Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients, Diabetic medicine : a journal of the British Diabetic Association, 2007, 24 (12) :1336 –1344

(8) Enia G, Panuccio V et al,Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis,Nephrology Dialysis Transplantation, 2007, 22(2):538 –544

(9)JohannAuer,PeterScheibner et al, Subclinical hyperthyroidism as a risk factor for atrial fibrillation,American Heart Journal,November 2001, 142(5):838-842

(10) Michel Chonchol, Giuseppe Lippi et al,Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease, Clinical journal of american society of nephrology,2008 Sep; 3(5):1296–1300.

(11)Lim VS, Thyroid function in patients with chronic renal failure American Journal of Kidney Diseases, 2001,38[4 Suppl 1]:80– 84

(12)Zoccali C, Tripepi G et al,Low triiodothyronine: a new facet of inflammation in end-stage renal disease.Journal of American Society of Nephrology, 2005,16(9):2789– 2795

(13)Zoccali C, Benedetto et al.Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.Journal of Hypertension, 2006, 24(10):2039– 2046.

(14)Zoccali C, Mallamaci F et al:Low triiodothyronine and survival in end-stage renal disease, Kidney International, 2006, 70(3):523– 528

(15) Carrero JJ, Qureshi AR et al,Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease,Journal of Internal Medicine, 2007, 262(6):690– 701

(16) AbhilashChandra, Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India,Kidney Research and Clinical Practice,September 2016,35(3):165-168

(17)Shantha G.P.S et al,Prevalence of Subclinical Hypothyroidism in Patients with End-Stage Renal Disease and the Role of Serum Albumin: A Cross-Sectional Study from South India, Cardiorenal Medicine, 2011;1(4):255–260


Refbacks

  • There are currently no refbacks.